- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6848 - Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Patent holdings for IPC class C12Q 1/6848
Total number of patents in this class: 892
10-year publication summary
|
36
|
45
|
81
|
120
|
89
|
120
|
140
|
81
|
102
|
37
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Natera, Inc. | 316 |
54 |
| Bio-Rad Laboratories, Inc. | 1611 |
32 |
| Life Technologies Corporation | 3286 |
23 |
| Gen-Probe Incorporated | 998 |
22 |
| Illumina, Inc. | 3337 |
21 |
| President and Fellows of Harvard College | 5964 |
12 |
| F. Hoffmann-La Roche AG | 7934 |
11 |
| Roche Molecular Systems, Inc. | 922 |
11 |
| Roche Sequencing Solutions, Inc. | 640 |
11 |
| Noul Co., Ltd. | 48 |
11 |
| Illumina Cambridge Limited | 683 |
9 |
| Integrated DNA Technologies, Inc. | 274 |
9 |
| New England BioLabs, Inc. | 490 |
9 |
| Lumiradx UK Ltd | 63 |
8 |
| Qiagen GmbH | 900 |
8 |
| Roche Diagnostics GmbH | 2689 |
7 |
| Pacific Biosciences of California, Inc. | 760 |
7 |
| Seegene, Inc. | 395 |
7 |
| Samplix ApS | 31 |
7 |
| Qiagen Sciences, LLC | 186 |
6 |
| Other owners | 607 |